- Home
- CDNA vs NX Comparison
CDNA vs NX Comparison
Compare CDNA & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- NX
- Stock Information
- Founded
- CDNA 1998
- NX 1927
- Country
- CDNA United States
- NX United States
- Employees
- CDNA N/A
- NX N/A
- Industry
- CDNA Medical Specialities
- NX Metal Fabrications
- Sector
- CDNA Health Care
- NX Industrials
- Exchange
- CDNA Nasdaq
- NX Nasdaq
- Market Cap
- CDNA 1.1B
- NX 1.1B
- IPO Year
- CDNA 2014
- NX N/A
- Fundamental
- Price
- CDNA $22.70
- NX $24.12
- Analyst Decision
- CDNA Buy
- NX Strong Buy
- Analyst Count
- CDNA 8
- NX 1
- Target Price
- CDNA $26.43
- NX $38.00
- AVG Volume (30 Days)
- CDNA 851.0K
- NX 511.2K
- Earning Date
- CDNA 02-26-2025
- NX 03-06-2025
- Dividend Yield
- CDNA N/A
- NX 1.31%
- EPS Growth
- CDNA N/A
- NX N/A
- EPS
- CDNA N/A
- NX 0.90
- Revenue
- CDNA $312,775,000.00
- NX $1,277,862,000.00
- Revenue This Year
- CDNA $19.85
- NX $50.17
- Revenue Next Year
- CDNA $11.34
- NX $2.87
- P/E Ratio
- CDNA N/A
- NX $26.87
- Revenue Growth
- CDNA 5.26
- NX 13.03
- 52 Week Low
- CDNA $7.42
- NX $21.48
- 52 Week High
- CDNA $34.84
- NX $39.31
- Technical
- Relative Strength Index (RSI)
- CDNA 50.19
- NX 44.64
- Support Level
- CDNA $21.09
- NX $21.48
- Resistance Level
- CDNA $25.95
- NX $24.22
- Average True Range (ATR)
- CDNA 1.67
- NX 0.76
- MACD
- CDNA 0.04
- NX 0.29
- Stochastic Oscillator
- CDNA 41.96
- NX 79.76
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.